IHL
Click for more information
0.00% 4.1¢ incannex healthcare limited

Ann: Fortrea to Manage IHL FDA IND Phase 2 and 3 Clinical Trial

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    18/07/23
    08:34
    Post #: 68834842
    Likes Created with Sketch. 71  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.